Analytical Data
-
基因名
PPAPDC3
- Application
-
别名
PLPP7; C9orf67; PPAPDC3; Inactive phospholipid phosphatase 7; Phosphatidic acid phosphatase type 2 domain-containing protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8NBV4
-
表达区间
1-271 aa
-
氨基酸序列
MPASQSRARARDRNNVLNRAEFLSLNQPPKGGPEPRSSGRKASGPSAQPPPAGDGARERRQSQQLPEEDCMQLNPSFKGIAFNSLLAIDICMSKRLGVCAGRAASWASARSMVKLIGITGHGIPWIGGTILCLVKSSTLAGQEVLMNLLLALLLDIMTVAGVQKLIKRRGPYEMSPSLLDYLTMDIYAFPAGHASRAAMVSKFFLSHLVLAVPLRVLLVLWALCVGLSRVMIGRHHVTDVLSGFVIGYLQFRLVELVWMPSSTCQMLISAW
-
分子量
55.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPAPDC3, or Phosphatidic Acid Phosphatase Domain Containing 3, is a vital member of the lipid metabolism family, playing a crucial role in the regulation of phospholipid signaling pathways. Recent studies have highlighted its potential involvement in various physiological processes, including cell proliferation, differentiation, and apoptosis. The dysregulation of PPAPDC3 has been associated with several diseases, particularly metabolic disorders and certain types of cancers, which emphasizes the need to explore its functional mechanisms further. Researchers are particularly interested in understanding how PPAPDC3 interacts with other cellular components and its implications in lipid signaling cascades. The recombinant expression of PPAPDC3 allows for detailed biochemical characterization and functional assays, providing insights into its enzymatic activity and substrate specificity. Furthermore, studying PPAPDC3 at a molecular level can reveal its potential as a therapeutic target, opening new avenues for drug development aimed at modulating lipid metabolism and addressing related diseases. Ultimately, the investigation into PPAPDC3's structure-function relationships and regulatory mechanisms may lead to significant advancements in our understanding of lipid biology and its clinical applications.
